Research & Development in Life SciencesAn in-depth article series |
Publish date:
Deloitte’s research & development (R&D) feature series is a selection of short articles that address critical challenges faced by the industry. Intended for Life Sciences R&D executives, these articles address multiple business areas and outline innovative and distinctive solutions to current and potential industry challenges. The series covers a broad and diverse set of vital business components including strategic vision, operational re-design, technology, talent management, and tax among others. Each article represents a snapshot of Deloitte’s point of view and is intended to foster further thinking and conversation regarding a particular issue.
| |
Innovative and Productive Pharmaceutical Research through Strategic Capability Management
|
| |
Secondary Uses of Electronic Health Record (EHR) Data in Life Science Research, Development and Post-marketing Surveillance
|
| |
Executing & Sustaining R&D Strategy
|
| Life Sciences R&D Talent Strategies: Remaining Competitive in the Emerging Markets Talent Pool This paper outlines key challenges and potential solutions for R&D talent management in emerging markets, with a focus on China and India. |
|
| Partnering Strategies in Life Sciences R&D This article describes a portfolio-based partnership approach that recognizes the unique economic profiles and risks of a diverse portfolio. Understanding each portfolio segment can help Life Science companies better identify the partner or partners best suited to meet their needs and help them retain the capabilities that provide competitive advantage. |
Additional articles that will be released in 2009:
- Scenario Planning in Life Sciences - Planning for Uncertainty
- Strategic Management of the Research Pipeline
- R&D Tax Credits
- The Value of Early Stage Life Science Companies
- Leveraging IT to Enable the Transition to the Virtual R&D Model
Related Content:
Resources: Catch the Life Sciences Wave
Overview: Life Sciences
Last updated

